European Investment Bank provided Immunic with €24.5 million to support development of COVID-19 therapy
On Oct. 20, 2020, the European Investment Bank (EIB) and Immunic announced the signing of a €24.5 million…
-
-
Agriculture | Artificial Intelligence | Biotechnology | CMO | CRO | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Department of Defense approved $87 million for newest bioindustrial manufacturing innovation institute
On Oct. 20, 2020, the U.S. Department of Defense announced an $87 million, seven-year award to the BioIndustrial…
-
Evidence review confirmed CDC guidance about infectivity of novel coronavirus
On Oct. 20, 2020, researchers at Oregon Health & Science University (OHSU) and Oregon State University (OSU) reported…
-
OPKO Health’s BioReference Laboratories launched multiplex COVID-19 and influenza A/B test
On Oct. 20, 2020, BioReference Laboratories, an OPKO Health company, announced that it was accepting specimens for a…
-
PerkinElmer immunoassay identiied therapeutic compounds capable of disrupting the SARS-CoV-2 spike protein/ACE2 interaction
On Oct. 20, 2020, PerkinElmer announced that a research team at the National Center for Advancing Translational Sciences…
-
Final report confirmed remdesivir benefits for COVID-19
On Oct. 20, 2020, the National Institutes of Health (NIH) has launched an adaptive Phase 3 clinical trial…
-
Just – Evotec Biologics received grant to enable an antibody product for the prevention of COVID-19
On Oct. 19, 2020, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics had received a grant…
-
BARDA reselected ICON as preferred partner to help strengthen U.S. emergency preparedness and response
On Oct. 19, 2020, ICON announced that it had been re-selected by the Biomedical Advanced Research and Development…
-
LabCorp launched quantitative antibody test to assess effectiveness of COVID-19 vaccines in clinical trials
On Oct. 19, 2020, LabCorp announced a test that provided a quantitative measurement of an individual’s SARS-CoV-2 IgG…
-
LabCorp and Swedish extended laboratory services relationship providing access to COVID-19 testing and diagnostics
On Oct. 19, 2020, LabCorp and Swedish, the largest nonprofit healthcare system in the Puget Sound region, announced…
-
Mateon’s phase 2 global study for OT-101/ TGF- Inhibitor against COVID-19 cleared for patient enrollment in Argentina
On Oct. 19, 2020, Mateon Therapeutics announced the receipt of approval from Republica Argentina Poder Ejecutivo Nacional, the…
-
Thermo Fisher Scientific increased availability of COVID-19 testing with sample collection kit from Everlywell
On Oct. 19, 2020, Thermo Fisher Scientific announced it had received an expansion of its Emergency Use Authorization…
-
Bio-Techne announced commercial release of SARS-CoV-2 multi-antigen serology assay kit for simple western
On Oct. 19, 2020, Bio-Techne announced that ProteinSimple, a Bio-Techne brand, released its SARS-CoV-2 Multi-Antigen Serology Module for…
-
RNA ‘ticker tape’ records gene activity over time
On Oct. 19, 2020, researchers at MIT, Harvard, and the Broad Institute of MIT announced they had developed…
-
Alberta Enterprise Corporation invested additional $5 million to benefit Alberta startups
On Oct. 19, 2020, Alberta Enterprise announced that it had invested an additional $5 million into its third…
-
Biotechnology | Genomics | Neurology | NIH
Study discovered gene that helps us know when it’s time to urinate
On Oct. 19, 2020, researchers announced they had discovered that a gene, called PIEZO2, may be responsible for…
-
U.S. DOD awarded $6.98 million to Teel Plastics to increase production of Swabsticks for COVID-19 testing
On Oct. 16, 2020, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
BD announce assay for immune assessment of COVID-19 patients available in Europe
On Oct. 16, 2020, BD (Becton, Dickinson) announced the CE mark and European availability of a product for…
-
NIH began large clinical trial to test immune modulators for treatment of COVID-19
On Oct. 16, 2020, the National Institutes of Health (NIH) launched an adaptive Phase 3 clinical trial to…
-
Ionis antisense medicine evaluated in an investigator-initiated clinical study of COVID-19 patients in Brazil
On Oct. 15, 2020, Ionis Pharmaceuticals announced that IONIS-PKK-LRx was being evaluated in an investigator-initiated Phase 2 clinical…
-
Entos announced spin-off company Aegis Life to support global vaccine commercialization
On Oct. 15, 2020, Entos Pharmaceuticals announces that its San Diego-based spinout company Aegis Life, will pursuing U.S….
-
Solidarity Therapeutics trial produced conclusive evidence on effectiveness of repurposed drugs for COVID-19
On Oct. 15, 2020, the World Health Organization (WHO) announced Interim that results from the Solidarity Therapeutics Trial,…
-
University of Oxford scientists developed extremely rapid diagnostic test for Covid-19
On Oct. 15, 2020, scientists from the University of Oxford’s Department of Physics announced they had developed an…
-
4D Nucleome Program Projects launched to map the nucleus, the information center of our cells
On Oct. 15, 2020 research teams from two divisions of the Allen Institute, the Allen Institute for Cell…
-
Tonix Pharmaceuticals enrolled first participant in PRECISION Study for COVID-19 vaccines and therapeutics
On Oct. 15, 2020, Tonix Pharmaceuticals announced that the first participant was enrolled in the observational PRECISION study…
-
Fred Hutch completed move-in of Lake Union Steam Plant
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
-
US DOD expanded collaboration with AstraZeneca to develop and manufacture an investigational mab to prevent COVID-19
On Oct. 14, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD)…
-
WHO announced position on genetically modified mosquitoes
On Oct. 14, 2020, recognizing the urgent need for new tools to combat vector-borne diseases (VBDs), and in…
-
FDA approved first treatment for Ebola virus
On Oct. 14, 2020, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceutical’s Inmazeb (atoltivimab, maftivimab, and…
-
Global tuberculosis progress at risk during COVID-19 pandemic
On Oct. 14, 2020, the World Health Organization (WHO) announced that prior to the COVID-19 pandemic, many countries…
